The pharmaceutical manufacturer BioSyn in Fellbach (Rems-Murr district) near Stuttgart had to stop producing a cancer drug some time ago after the manufacturing costs became too high. As a result, there was a shortage in the market. Even the political measures did not change this. Managing director Andreas Meyer explains why.
2023-09-11 19:33:40
#Drug #shortages #Fellbach #company #BioSyn #discussion
Related posts:
This is the most expensive mansion in Ohio, United States, which was put up for sale for nearly 20 b...
Europe is preventing for independence. Ariane 6 able to obtain
How to Make Money Collecting and Selling Scrap Metal: Factors Affecting Aluminum Prices
"New Temporary Signs in Bratislava Remind Drivers Not to Block Intersections on Green Light"
